These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 894751)

  • 1. In vitro studies of chemical mutagens and carcinogens. I. Stability studies in cell culture medium.
    Jensen EM; LaPolla RJ; Kirby PE; Haworth SR
    J Natl Cancer Inst; 1977 Sep; 59(3):941-4. PubMed ID: 894751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.
    McCann J; Choi E; Yamasaki E; Ames BN
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5135-9. PubMed ID: 1061098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays.
    Matthews EJ; Spalding JW; Tennant RW
    Environ Health Perspect; 1993 Jul; 101 Suppl 2(Suppl 2):347-482. PubMed ID: 8243403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenic activity of chemical carcinogens and related compounds in the intraperitoneal host-mediated assay.
    Simmon VF; Rosenkranz HS; Zeiger E; Poirier LA
    J Natl Cancer Inst; 1979 Apr; 62(4):911-8. PubMed ID: 372659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals: discussion.
    McCann J; Ames BN
    Proc Natl Acad Sci U S A; 1976 Mar; 73(3):950-4. PubMed ID: 768988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical carcinogens as frameshift mutagens: Salmonella DNA sequence sensitive to mutagenesis by polycyclic carcinogens.
    Isono K; Yourno J
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1612-7. PubMed ID: 4525453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-arabinose resistance test with Salmonella typhimurium as a primary tool for carcinogen screening.
    Dorado G; Pueyo C
    Cancer Res; 1988 Feb; 48(4):907-12. PubMed ID: 3276401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of carcinogens and related compounds tested for mutagenic activity.
    Poirier LA; Weisburger EK
    J Natl Cancer Inst; 1979 Apr; 62(4):833-40. PubMed ID: 372655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination of half-lifetimes and mutagenic concentrations of chemical carcinogens using a diffusion bioassay.
    Awerbuch TE; Sinskey AJ
    Mutat Res; 1980 Apr; 74(2):125-43. PubMed ID: 6769034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine bladder urothelial cell activation of carcinogens to metabolites mutagenic to Chinese hamster V79 cells and Salmonella typhimurium.
    Oglesby LA; Hix C; Snow L; MacNair P; Seig M; Langenbach R
    Cancer Res; 1983 Nov; 43(11):5194-9. PubMed ID: 6352016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical carcinogens without mutagenic activity: peroxisome proliferators as a prototype.
    Reddy JK; Scarpelli DG; Subbarao V; Lalwani ND
    Toxicol Pathol; 1983; 11(2):172-80. PubMed ID: 6399165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative predictivity of the transformation in vitro assay compared with the Ames test.
    Parodi S; Taningher M; Russo P; Pala M; Vecchio D; Fassina G; Santi L
    J Toxicol Environ Health; 1983; 12(4-6):483-510. PubMed ID: 6668607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Literature survey of bacterial, fungal, and Drosophila assay systems used in the evaluation of selected chemical compounds for mutagenic activity.
    Brown MM; Wassom JS; Malling HV; Shelby MD; Von Halle ES
    J Natl Cancer Inst; 1979 Apr; 62(4):841-71. PubMed ID: 155170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro mutagenesis assays as predictors of chemical carcinogenesis in mammals.
    Brusick DJ
    Clin Toxicol; 1977; 10(1):79-109. PubMed ID: 404113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenic and alkylating activities of 3-methyl-1-phenyltriazenes and their possible role as carcinogenic metabolites of the parent dimethyl compounds.
    Malaveille C; Brun G; Kolar G; Bartsch H
    Cancer Res; 1982 Apr; 42(4):1446-53. PubMed ID: 7060018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative comparisons between carcinogenicity, mutagenicity and electrophilicity of direct-acting N-nitroso compounds and other alkylating agents.
    Bartsch H; Malaveille C; Tomatis L; Brun G; Dodet B; Terracini B
    IARC Sci Publ; 1982; (41):525-32. PubMed ID: 6754595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis.
    Beland FA; Beranek DT; Dooley KL; Heflich RH; Kadlubar FF
    Environ Health Perspect; 1983 Mar; 49():125-34. PubMed ID: 6339219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of aromatic amines to mutagens by bovine bladder and liver cells.
    Oglesby L; Hix-Baker C; MacNair P; Sieg M; Snow L; Langenbach R
    Environ Health Perspect; 1983 Mar; 49():147-54. PubMed ID: 6339223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.